ALL Allstate (ALL) Insider Trading, Ownership & Congress Trades
Insurance · Fire, marine & casualty insurance · CIK 0000899051
Form 144 · 2
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
881
13F, latest reported quarter
Conversions, 180 days
15
Codes C/M, not in net · $7.0M priced
What the filings say about ALL
Insiders, 180 days
-$28.6M net sold
4 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
0 bought · 1 sold
Latest: sale, 2026-08-12
Planned sales (Form 144), 90 days
$23.8M
2 notices
Allstate insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, ALLSTATE CORP insiders sold a net $28.6M of stock across 150 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on May 1, 2026.
- The trade is 45.7% of the 95,054 shares held after it.
- 1 other insider sold within 30 days.
- 881 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Rizzo Mario sold about $11.5M of ALL on Aug 11, 2026, the largest insider sale at the company since 2024; 1 other insider sold within 30 days and 881 funds added in the latest 13F quarter.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on May 1, 2026.
- The trade is 15.6% of the 82,227 shares held after it.
- 1 other insider sold within 30 days.
- 881 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Rizzo Mario sold about $3.4M of ALL on Aug 11, 2026; 1 other insider sold within 30 days and 881 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Sep 20, 2024.
- The trade is 7.9% of the 42,672 shares held after it.
- 1 other insider sold within 30 days.
- 881 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Dugenske John E sold about $912.7K of ALL on Aug 7, 2026; 1 other insider sold within 30 days and 881 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Sep 20, 2024.
- The trade is 10.1% of the 38,771 shares held after it.
- 1 other insider sold within 30 days.
- 881 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Dugenske John E sold about $1.1M of ALL on Aug 7, 2026; 1 other insider sold within 30 days and 881 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Sep 20, 2024.
- The trade is 197.0% of the 13,054 shares held after it.
- 1 other insider sold within 30 days.
- 881 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Dugenske John E sold about $6.9M of ALL on Aug 7, 2026, the largest insider sale at the company since 2025; 1 other insider sold within 30 days and 881 funds added in the latest 13F quarter.150 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$28.6M over 180 days
-$23.8M over 90 days
below 87% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
881 funds bought in last quarter
more than 95% of Insurance
Revenue
+5.6% year over year
below 62% of Insurance
Margin
15.2% net margin
more than 62% of Insurance
Buybacks
$1.7B repurchased, FY to 2026-06-30
more than 93% of Insurance
Short interest
2.8% of the float short (float per yahoo 2026-10-26) · 2.4 days to cover · settled 2026-09-30
below 51% of Insurance
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch ALL
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+33.4%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns ALL: institutional holders (13F)
13F holdings, latest reported quarter
22,860,586 sh
$5.4B
16,810,820 sh
$4.0B
13,614,924 sh
$3.2B
12,510,392 sh
$3.0B
8,696,007 sh
$2.1B
Congress trades in ALL
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2026-08-12 · disclosed 21 days later
$1,001 - $15,000
Sold 2025-04-07 · disclosed 37 days later
$1,001 - $15,000
Sold 2024-07-05 · disclosed 32 days later
$1,001 - $15,000
Sold 2024-07-05 · disclosed 45 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
ALL planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Rizzo Mario
Filed 2026-08-11
$14.9M
Dugenske John E
Filed 2026-08-07
$8.9M
Prindiville Mark Q
Filed 2026-06-22
$1.1M
ALL mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
BRUCE FUND
$26.2M position · as of 2026-06-30
7.0%
iShares U.S. Insurance ETF
$27.6M position · as of 2026-06-30
6.6%
Poplar Forest Partners Fund
$17.3M position · as of 2026-06-30
4.5%
NVIT GQG US Quality Equity Fund
$3.8M position · as of 2026-06-30
4.4%
Invesco KBW Property & Casualty Insurance ETF
$10.1M position · as of 2026-05-31
4.2%
Buffalo Flexible Allocation Fund
$19.0M position · as of 2026-06-30
4.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Wilson
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$22.9M
$45.1M
$6.5M
+114%
+114%
2024
$26.7M
$57.0M
$7.6M
+94%
+100%
2023
$16.5M
$8.0M
$4.5M
+38%
+58%
2022
$15.0M
$30.0M
$3.5M
+30%
+49%
2021
$19.1M
$27.6M
$5.5M
+10%
+31%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $28.6M sold by insiders over 180 days, 881 funds added last quarter, $23.8M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
ALL financials
Revenue growth
+5.6%
XBRL, annual
Net margin
15.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$70.1B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM ALL
| FY Dec 2025 | $67.7B |
| FY Dec 2024 | $64.1B |
| FY Dec 2023 | $57.1B |
| FY Dec 2022 | $51.4B |
| FY Dec 2021 | $50.6B |
| Jun 2026 | $18.6B |
| Mar 2026 | $16.9B |
| Dec 2025 | $17.3B |
| Sep 2025 | $17.3B |
| Jun 2025 | $16.6B |
| Mar 2025 | $16.5B |
| Dec 2024 | $16.5B |
| Sep 2024 | $16.6B |
At each fiscal year end
Single quarter
Net margin, TTM
+18.8%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM ALL
| FY Dec 2025 | +15.0% |
| FY Dec 2024 | +7.1% |
| FY Dec 2023 | -0.6% |
| FY Dec 2022 | -2.8% |
| FY Dec 2021 | +2.9% |
| Jun 2026 | +17.6% |
| Mar 2026 | +14.5% |
| Dec 2025 | +21.4% |
| Sep 2025 | +21.7% |
| Jun 2025 | +12.7% |
| Mar 2025 | +3.6% |
| Dec 2024 | +11.0% |
| Sep 2024 | +7.2% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$12.2B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM ALL
| FY Dec 2025 | $9.9B |
| FY Dec 2024 | $8.7B |
| FY Dec 2023 | $4.0B |
| FY Dec 2022 | $4.7B |
| FY Dec 2021 | $4.8B |
| Jun 2026 | $2.6B |
| Mar 2026 | $3.5B |
| Dec 2025 | $2.9B |
| Sep 2025 | $3.2B |
| Jun 2025 | $1.9B |
| Mar 2025 | $1.9B |
| Dec 2024 | $1.7B |
| Sep 2024 | $3.1B |
At each fiscal year end
Single quarter
Debt to equity
0.22x
long-term debt only, 2026-06-30; equity 2026-06-30
Debt to equity ALL
| FY Dec 2025 | 0.24x |
| FY Dec 2024 | 0.38x |
| FY Dec 2023 | 0.45x |
| FY Dec 2022 | 0.46x |
| FY Dec 2021 | 0.32x |
| Jun 2026 | 0.22x |
| Mar 2026 | 0.24x |
| Dec 2025 | 0.24x |
| Sep 2025 | 0.29x |
| Jun 2025 | 0.34x |
| Mar 2025 | 0.37x |
| Dec 2024 | 0.38x |
| Sep 2024 | 0.39x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
1.66x
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt ALL
| FY Dec 2025 | 1.35x |
| FY Dec 2024 | 1.10x |
| FY Dec 2023 | 0.53x |
| FY Dec 2022 | 0.64x |
| FY Dec 2021 | 0.64x |
| Jun 2026 | 1.66x |
| Mar 2026 | 1.56x |
| Dec 2025 | 1.35x |
| Sep 2025 | 1.09x |
| Jun 2025 | 1.08x |
| Mar 2025 | 1.14x |
| Dec 2024 | 1.10x |
| Sep 2024 | 1.05x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+45.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity ALL
| FY Dec 2025 | +39.1% |
| FY Dec 2024 | +23.2% |
| FY Dec 2023 | -1.8% |
| FY Dec 2022 | -6.7% |
| FY Dec 2021 | +5.4% |
| Jun 2026 | +45.7% |
| Mar 2026 | +44.8% |
| Dec 2025 | +39.1% |
| Sep 2025 | +34.1% |
| Jun 2025 | +26.8% |
| Mar 2025 | +19.3% |
| Dec 2024 | +23.2% |
| Sep 2024 | +23.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+11.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ALL
| FY Dec 2025 | +8.8% |
| FY Dec 2024 | +4.2% |
| FY Dec 2023 | -0.3% |
| FY Dec 2022 | -1.4% |
| FY Dec 2021 | +1.3% |
| Jun 2026 | +11.0% |
| Mar 2026 | +10.1% |
| Dec 2025 | +8.8% |
| Sep 2025 | +7.1% |
| Jun 2025 | +5.1% |
| Mar 2025 | +3.6% |
| Dec 2024 | +4.2% |
| Sep 2024 | +3.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital ALL
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed ALL
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
5.11x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing ALL
| FY Dec 2025 | 5.45x |
| FY Dec 2024 | 11.35x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 23.07x |
| Jun 2026 | 4.75x |
| Mar 2026 | 4.57x |
| Dec 2025 | 5.45x |
| Sep 2025 | 6.95x |
| Jun 2025 | 9.46x |
| Mar 2025 | 14.14x |
| Dec 2024 | 11.35x |
| Sep 2024 | 12.28x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no cash line filed
Enterprise value ALL
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+18.9%
TTM free cash flow over market value at close 2026-10-26
FCF yield ALL
| FY Dec 2025 | +18.1% |
| FY Dec 2024 | +17.1% |
| FY Dec 2023 | +10.8% |
| FY Dec 2022 | +13.1% |
| FY Dec 2021 | +14.1% |
| Jun 2026 | +20.0% |
| Mar 2026 | +21.4% |
| Dec 2025 | +18.1% |
| Sep 2025 | +15.3% |
| Jun 2025 | +16.0% |
| Mar 2025 | +16.3% |
| Dec 2024 | +17.1% |
| Sep 2024 | +16.4% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.04x
P/E over trailing EPS growth of 135%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing ALL
| FY Dec 2025 | 0.04x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | 0.04x |
| Mar 2026 | 0.02x |
| Dec 2025 | 0.04x |
| Sep 2025 | 0.07x |
| Jun 2025 | 0.10x |
| Mar 2025 | 0.06x |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $67.7B | $64.1B | $57.1B | $51.4B |
| Net income | $10.2B | $4.5B | -$316.0M | -$1.4B |
| EPS (diluted) | 38.06 | 16.99 | -1.20 | -5.14 |
| Operating cash flow | $10.1B | $8.9B | $4.2B | $5.1B |
| Long-term debt | $7.5B | $8.1B | $7.9B | $8.0B |
| Buybacks | $1.2B | $2.0M | $335.0M | $2.5B |
| Dividends paid | $1.0B | $962.0M | $925.0M | $926.0M |
SEC XBRL, fiscal years, as known on 2026-10-27
ALL Stock Sonar score 6/7 axes
Find similar shapesCompareALL ranks highest on profitability (96th percentile) and financial health (72nd), and lowest on insider conviction (7th), among Insurance peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ALL filings, in plain words
Are Allstate insiders buying or selling ALL?
In the 180 days to 2026-10-27, Allstate insiders were net sellers, a net $28.6M across purchases and sales reported on Form 4, by 4 sellers.
Have members of Congress traded ALL?
Yes. In the year to 2026-10-27, 0 House members disclosed buying ALL and 1 House member disclosed selling it; the latest on record is a sale by Michael Rulli dated 2026-08-12.
Are there planned insider sales of ALL?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $23.8M of stock; the latest, by Rizzo Mario, was filed 2026-08-11.
Read the full summary
In the 180 days to 2026-10-27, Allstate insiders were net sellers of ALL, a net $28.6M across purchases and sales reported on Form 4 by 4 sellers. None of the 8 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-27, 0 members of Congress disclosed buying ALL and 1 member disclosed selling it; the latest on record is a sale by Michael Rulli dated 2026-08-12. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $23.8M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
